Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease

Aging

Volumn 6, Issue 4, 2014, Pages 281-295

  Sheedfar, Fareeba ^a   Sung, Miranda M Y ^b   Aparicio Vergara, Marcela ^a   Kloosterhuis, Niels J ^a   Miquilena Colina, Maria Eugenia ^c   Vargas Castrillón, Javier ^c   Febbraio, Maria ^d   Jacobs, René L ^d   de Bruin, Alain ^e   Vinciguerra, Manlio ^f,g   García Monzón, Carmelo ^c   Hofker, Marten H ^a   Dyck, Jason R B ^b   Koonen, Debby P Y ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UTRECHT UNIVERSITY   (Netherlands)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Aging; CD36; Inflammation; Liver; NAFLD; NASH; Obesity; Steatosis

Indexed keywords

CD36 ANTIGEN;

ADULT; AGED; AGING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MEMBRANE; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; MALE; METABOLISM; MIDDLE AGED; MOUSE; NONALCOHOLIC FATTY LIVER; REAL TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

ADULT; AGED; AGING; ANIMALS; ANTIGENS, CD36; CELL MEMBRANE; FEMALE; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84900478772     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100652     Document Type: Article

References (46)

1. WHO. What are the public health implications of global ageing? World Heal. Organ. 2011;.
2. WHO. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva, Switzerland. World Heal. Organ. 2009;.
3. Erickson SK. Nonalcoholic fatty liver disease. J. Lipid Res. 2009;50 Suppl:S412-416.
4. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010;7:195-203.
5. Floreani A. Liver diseases in the elderly: an update. Dig. Dis. 2007;25:138-143.
6. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res. Rev. 2006;5:144-164.
7. Frith J, Day CP, Henderson E, Burt AD, Newton JL. Nonalcoholic fatty liver disease in older people. Gerontology. 2009;55:607-613.
8. Regev A, Schiff ER. Liver disease in the elderly. Gastroenterol. Clin. North Am. 2001;30:547-63.
9. Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseases and aging: friends or foes? Aging Cell. 2013;12:950-954.
10. Ghosh PM, Shu Z-J, Zhu B, Lu Z, Ikeno Y, Barnes JL, Yeh C-K, Zhang B-X, Katz MS, Kamat A. Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging. J. Endocrinol. 2012;213:251-261.
11. Honma T, Yanaka M, Tsuduki T, Ikeda I. Increased lipid accumulation in liver and white adipose tissue in aging in the SAMP10 mouse. J. Nutr. Sci. Vitaminol. (Tokyo). 2011;57:123-129.
12. Jin J, Iakova P, Breaux M, Sullivan E, Jawanmardi N, Chen D, Jiang Y, Medrano EM, Timchenko NA. Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep. 2013;3:831-843.
13. Bieghs V, Wouters K, van Gorp PJ, Gijbels MJJ, de Winther MPJ, Binder CJ, Lütjohann D, Febbraio M, Moore KJ, van Bilsen M, Hofker MH, Shiri-Sverdlov R. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology. 2010;138:2477-86, 2486.e1-3.
14. Fontana L, Zhao E, Amir M, Dong H, Tanaka K, Czaja MJ. Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology. 2013;57:995-1004.
15. Koonen DPY, Glatz JFC, Bonen A, Luiken JJFP. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim. Biophys. Acta. 2005;1736:163-180.
16. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JFC, Luiken JJFP, Heigenhauser GJF, Dyck DJ. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 2004;18:1144-1146.
17. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 2001;276:40567-40573.
18. Koonen DPY, Jacobs RL, Febbraio M, Young ME, Soltys C-LM, Ong H, Vance DE, Dyck JRB. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 2007;56:2863-2671.
19. Koonen DPY, Febbraio M, Bonnet S, Nagendran J, Young ME, Michelakis ED, Dyck JRB. CD36 expression contributes to ageinduced cardiomyopathy in mice. Circulation. 2007;116:2139-2147.
20. Koonen DPY, Sung MMY, Kao CKC, Dolinsky VW, Koves TR, Ilkayeva O, Jacobs RL, Vance DE, Light PE, Muoio DM, Febbraio M, Dyck JRB. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes. 2010;59:1366-1375.
21. Sung MMY, Koonen DPY, Soltys C-LM, Jacobs RL, Febbraio M, Dyck JRB. Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction. J. Mol. Med. (Berl). 2011;89:459-469.
22. Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol. Pathol. 2012;40:71-82.
23. Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H. A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. Lab. Invest. 2012;92:265-281.
24. Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 2011;60:1394-1402.
25. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140-1142.
26. Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, et al. Rosiglitazone attenuates age-and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. Hepatology. 2010;52:2001-2011.
27. Houtkooper RH, Argmann C, Houten SM, Cantó C, Jeninga EH, Andreux PA, Thomas C, Doenlen R, Schoonjans K, Auwerx J. The metabolic footprint of aging in mice. Sci. Rep. 2011;1.
28. Luiken JJFP, Koonen DPY, Willems J, Zorzano A, Becker C, Fischer Y, Tandon NN, Van Der Vusse GJ, Bonen A, Glatz JFC. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes. 2002;51:3113-3119.
29. Buqué X, Cano A, Miquilena-Colina ME, García-Monzón C, Ochoa B, Aspichueta P. High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes. Am. J. Physiol. Endocrinol. Metab. 2012;303:E504-514.
30. Kim K-Y, Stevens M V, Akter MH, Rusk SE, Huang RJ, Cohen A, et al. Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J. Clin. Invest. 2011;121:3701-3712.
31. Ehehalt R, Füllekrug J, Pohl J, Ring A, Herrmann T, Stremmel W. Translocation of long chain fatty acids across the plasma membrane-lipid rafts and fatty acid transport proteins. Mol. Cell. Biochem. 2006;284:135-140.
32. Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL, Xie W. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 2008;134:556-567.
33. Chang AM, Halter JB. Aging and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2003;284:E7-12.
34. Bonen A, Benton CR, Campbell SE, Chabowski A, Clarke DC, Han X-X, Glatz JFC, Luiken JJFP. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes. Acta Physiol. Scand. 2003;178:347-356.
35. Coort SLM, Hasselbaink DM, Koonen DPY, Willems J, Coumans WA, Chabowski A, van der Vusse GJ, Bonen A, Glatz JFC, Luiken JJFP. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes. 2004;53:1655-1663.
36. Schwenk RW, Luiken JJFP, Bonen A, Glatz JFC. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc. Res. 2008;79:249-258.
37. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am. J. Physiol. 1998;274:E210-217.
38. Smith J, Su X, El-Maghrabi R, Stahl PD, Abumrad NA. Opposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake. J. Biol. Chem. 2008;283:13578-13585.
39. Liang C-P, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, Tall AR. Increased CD36 protein as a response to defective insulin signaling in macrophages. J. Clin. Invest. 2004;113:764-773.
40. Choo YS, Vogler G, Wang D, Kalvakuri S, Iliuk A, Tao WA, Bodmer R, Zhang Z. Regulation of parkin and PINK1 by neddylation. Hum. Mol. Genet. 2012;21:2514-2523.
41. Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh S V, Tsujita T, Dillon JF, Ashford MLJ, Hayes JD. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2010;48:357-371.
42. Gems D, Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu. Rev. Physiol. 2013;75:621-644.
43. Blagosklonny M V. Answering the ultimate question "what is the proximal cause of aging?". Aging (Albany. NY). 2012;4:861-877.
44. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999;94:2467-2474.
45. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
46. Jacobs RL, Devlin C, Tabas I, Vance DE. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J. Biol. Chem. 2004;279:47402-47410.